North America Cardiac Rhythm Management Devices Market Outlook to 2033 - Cardiac Resynchronisation Therapy (CRT), Implantable Cardioverter Defibrillators (ICD) and Pacemakers

Description

List of Tables

GlobalData's "North America Cardiac Rhythm Management Devices Market Outlook to 2033" is a comprehensive databook report, covering key market data on the North America Cardiac Rhythm Management Devices market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Cardiac Resynchronisation Therapy (CRT), Implantable Cardioverter Defibrillators (ICD) and Pacemakers

The North America Cardiac Rhythm Management Devices Market report provides key information and data on -

Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
2024 company share data for Cardiac Rhythm Management Devices Market.
Global corporate-level profiles of key companies operating within the North America Cardiac Rhythm Management Devices Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

North America Cardiac Rhythm Management Devices is segmented as follows -

Cardiac Resynchronisation Therapy (CRT)
Implantable Cardioverter Defibrillators (ICD)
Pacemakers

Reasons to Buy

The North America Cardiac Rhythm Management Devices Market report helps you to develop -

Business strategies by identifying the key market segments poised for strong growth in the future.
Market-entry and market expansion strategies.
Design competition strategies by identifying who-stands-where in the market.
Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
Understand the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Product Code: GDME21540CRDB

1 Table of Contents

1.1 List of Tables
1.2 List of Figures

2 Introduction

2.1 What Is This Report About?
2.2 Cardiac Rhythm Management Devices Market Segmentation
2.3 Definitions of Markets Covered in the Report

3 Cardiac Rhythm Management Devices Market, North America

3.1 Cardiac Rhythm Management Devices Market, North America, Revenue ($m), 2018-2033
3.2 Cardiac Rhythm Management Devices Market, North America, Revenue ($m), 2018-2033
3.3 Cardiac Rhythm Management Devices Market, North America, Volume (Units), 2018-2033
3.4 Cardiac Rhythm Management Devices Market, North America, Volume (Units), 2018-2033
3.5 Cardiac Rhythm Management Devices Market, North America, Company Share by Revenue ($m), 2024

4 Cardiac Rhythm Management Devices Market, Canada

4.1 Cardiac Rhythm Management Devices Market, Canada, Revenue ($m), 2018-2033
- 4.1.1 Cardiac Resynchronisation Therapy (CRT) Market, Canada, Revenue ($m), by Segment, 2018-2033
- 4.1.2 Implantable Cardioverter Defibrillators (ICD) Market, Canada, Revenue ($m), by Segment, 2018-2033
- 4.1.3 Pacemakers Market, Canada, Revenue ($m), by Segment, 2018-2033
4.2 Cardiac Rhythm Management Devices Market, Canada, Volume (Units), 2018-2033
- 4.2.1 Cardiac Resynchronisation Therapy (CRT) Market, Canada, Volume (Units), by Segment, 2018-2033
- 4.2.2 Implantable Cardioverter Defibrillators (ICD) Market, Canada, Volume (Units), by Segment, 2018-2033
- 4.2.3 Pacemakers Market, Canada, Volume (Units), by Segment, 2018-2033
4.3 Cardiac Rhythm Management Devices Market, Canada, Average Price ($) , 2018-2033
4.4 Cardiac Rhythm Management Devices Market, Canada, Company Share by Revenue ($m), 2024

5 Cardiac Rhythm Management Devices Market, Mexico

5.1 Cardiac Rhythm Management Devices Market, Mexico, Revenue ($m), 2018-2033
- 5.1.1 Cardiac Resynchronisation Therapy (CRT) Market, Mexico, Revenue ($m), by Segment, 2018-2033
- 5.1.2 Implantable Cardioverter Defibrillators (ICD) Market, Mexico, Revenue ($m), by Segment, 2018-2033
- 5.1.3 Pacemakers Market, Mexico, Revenue ($m), by Segment, 2018-2033
5.2 Cardiac Rhythm Management Devices Market, Mexico, Volume (Units), 2018-2033
- 5.2.1 Cardiac Resynchronisation Therapy (CRT) Market, Mexico, Volume (Units), by Segment, 2018-2033
- 5.2.2 Implantable Cardioverter Defibrillators (ICD) Market, Mexico, Volume (Units), by Segment, 2018-2033
- 5.2.3 Pacemakers Market, Mexico, Volume (Units), by Segment, 2018-2033
5.3 Cardiac Rhythm Management Devices Market, Mexico, Average Price ($), 2018-2033
5.4 Cardiac Rhythm Management Devices Market, Mexico, Company Share by Revenue ($m), 2024

6 Cardiac Rhythm Management Devices Market, United States

6.1 Cardiac Rhythm Management Devices Market, United States, Revenue ($m), 2018-2033
- 6.1.1 Cardiac Resynchronisation Therapy (CRT) Market, United States, Revenue ($m), by Segment, 2018-2033
- 6.1.2 Implantable Cardioverter Defibrillators (ICD) Market, United States, Revenue ($m), by Segment, 2018-2033
- 6.1.3 Pacemakers Market, United States, Revenue ($m), by Segment, 2018-2033
6.2 Cardiac Rhythm Management Devices Market, United States, Volume (Units), 2018-2033
- 6.2.1 Cardiac Resynchronisation Therapy (CRT) Market, United States, Volume (Units), by Segment, 2018-2033
- 6.2.2 Implantable Cardioverter Defibrillators (ICD) Market, United States, Volume (Units), by Segment, 2018-2033
- 6.2.3 Pacemakers Market, United States, Volume (Units), by Segment, 2018-2033
6.3 Cardiac Rhythm Management Devices Market, United States, Average Price ($), 2018-2033
6.4 Cardiac Rhythm Management Devices Market, United States, Company Share by Revenue ($m), 2024

7 Overview of Key Companies in North America Cardiac Rhythm Management Devices Market

7.1 Medtronic Plc
- 7.1.1 Company Overview
7.2 Abbott Laboratories
- 7.2.1 Company Overview
7.3 Boston Scientific Corp
- 7.3.1 Company Overview
7.4 Biotronik SE & Co KG
- 7.4.1 Company Overview

8 Cardiac Rhythm Management Devices Market Pipeline Products

9 Recent Developments

9.1 Corporate Communications
- 9.1.1 Jul 08, 2025: Medtronic Appoints Chad Spooner as Chief Financial Officer of MiniMed
- 9.1.2 May 21, 2025: Medtronic Announces Leadership Change in Cardiovascular Portfolio
9.2 Financial Announcements
- 9.2.1 Sep 02, 2025: Boston Scientific Announces 2025 Investor Day Meeting and Conference Call Discussing Third Quarter 2025 Results
- 9.2.2 Jul 31, 2025: iRhythm Technologies Announces Second Quarter 2025 Financial Results
- 9.2.3 Apr 15, 2025: Orthofix to Report First Quarter 2025 Financial Results
- 9.2.4 Apr 07, 2025: CVRx Announces Preliminary Q1 2025 Results
- 9.2.5 Jan 28, 2025: Orthofix to Report Fourth Quarter and Full-Year 2024 Financial Results
- 9.2.6 Jan 21, 2025: CVRx to Report Fourth Quarter 2024 Financial and Operating Results and Host Conference Call on February 4, 2025
- 9.2.7 Nov 07, 2024: Orthofix Reports Third Quarter 2024 Results, Reiterates Full-Year 2024 Financial Guidance, and Introduces New Three-Year Financial Targets
- 9.2.8 Oct 23, 2024: Boston Scientific Reports Results for Q3 2024
- 9.2.9 Oct 10, 2024: Orthofix to Report Third Quarter 2024 Financial Results
- 9.2.10 Oct 02, 2024: Boston Scientific Announces Conference Call Discussing Third Quarter 2024 Results
9.3 Government and Public Interest
- 9.3.1 Aug 20, 2025: iRhythm Technologies to Participate in Upcoming Investor Conferences
- 9.3.2 Jun 19, 2025: Mah Sing Healthcare Sdn Bhd Receives 510(K) Clearance For Nitrile Powder Free Examination Glove with Tremella Fuciformis Extract
- 9.3.3 May 01, 2025: Boston Scientific Announces Upcoming Investor Conference Schedule
- 9.3.4 Mar 03, 2025: Orthofix to Participate in the 37th Annual Roth Conference
- 9.3.5 Nov 12, 2024: Orthofix to Participate in Upcoming Investor Conferences
- 9.3.6 Oct 21, 2024: Orthofix to Participate in Stifel 2024 Healthcare Conference
9.4 Product News
- 9.4.1 Feb 03, 2025: Integer to Showcase Leadership in Medical Device Innovation and Recent Acquisition of Precision Coating at MD&M West 2025
- 9.4.2 Sep 26, 2024: Engineering Human Heart Tissue for Scientific Study
9.5 Strategy And Business Planning
- 9.5.1 Jan 28, 2025: EBR Leases New Facility to Expand Manufacturing Capabilities

10 Appendix

10.1 Research Methodology
- 10.1.1 Coverage
- 10.1.2 Secondary Research
- 10.1.3 Primary Research
- 10.1.4 Market Modeling and Forecasting
- 10.1.5 Company Share Analysis
- 10.1.6 Benchmarking
10.2 GlobalData Consulting
10.3 Contact Us
10.4 Disclaimer

Product Code: GDME21540CRDB

List of Table

List of Tables

Table 1: Cardiac Rhythm Management Devices Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2018-2033
Table 2: Cardiac Rhythm Management Devices Market, North America, Revenue ($m), USD Constant, 2018-2033
Table 3: Cardiac Rhythm Management Devices Market, North America, Volume (Units), 2018-2033
Table 4: Cardiac Rhythm Management Devices Market, North America, Volume (Units), 2018-2033
Table 5: Cardiac Rhythm Management Devices Market, North America, Company Share by Revenue ($m), 2024
Table 6: Cardiac Rhythm Management Devices Market, Canada, Revenue ($m), USD Constant, 2018-2033
Table 7: Cardiac Resynchronisation Therapy (CRT) Market, Canada, Revenue ($m), USD Constant, 2018-2033
Table 8: Implantable Cardioverter Defibrillators (ICD) Market, Canada, Revenue ($m), USD Constant, 2018-2033
Table 9: Pacemakers Market, Canada, Revenue ($m), USD Constant, 2018-2033
Table 10: Cardiac Rhythm Management Devices Market, Canada, Volume (Units), 2018-2033
Table 11: Cardiac Resynchronisation Therapy (CRT) Market, Canada, Volume (Units), 2018-2033
Table 12: Implantable Cardioverter Defibrillators (ICD) Market, Canada, Volume (Units), 2018-2033
Table 13: Pacemakers Market, Canada, Volume (Units), 2018-2033
Table 14: Cardiac Rhythm Management Devices Market, Canada, Average Price ($), 2018-2033
Table 15: Cardiac Rhythm Management Devices Market, Canada, Company Share by Revenue ($m), 2024
Table 16: Cardiac Rhythm Management Devices Market, Mexico, Revenue ($m), USD Constant, 2018-2033
Table 17: Cardiac Resynchronisation Therapy (CRT) Market, Mexico, Revenue ($m), USD Constant, 2018-2033
Table 18: Implantable Cardioverter Defibrillators (ICD) Market, Mexico, Revenue ($m), USD Constant, 2018-2033
Table 19: Pacemakers Market, Mexico, Revenue ($m), USD Constant, 2018-2033
Table 20: Cardiac Rhythm Management Devices Market, Mexico, Volume (Units), 2018-2033
Table 21: Cardiac Resynchronisation Therapy (CRT) Market, Mexico, Volume (Units), 2018-2033
Table 22: Implantable Cardioverter Defibrillators (ICD) Market, Mexico, Volume (Units), 2018-2033
Table 23: Pacemakers Market, Mexico, Volume (Units), 2018-2033
Table 24: Cardiac Rhythm Management Devices Market, Mexico, Average Price ($), 2018-2033
Table 25: Cardiac Rhythm Management Devices Market, Mexico, Company Share by Revenue ($m), 2024
Table 26: Cardiac Rhythm Management Devices Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 27: Cardiac Resynchronisation Therapy (CRT) Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 28: Implantable Cardioverter Defibrillators (ICD) Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 29: Pacemakers Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 30: Cardiac Rhythm Management Devices Market, United States, Volume (Units), 2018-2033
Table 31: Cardiac Resynchronisation Therapy (CRT) Market, United States, Volume (Units), 2018-2033
Table 32: Implantable Cardioverter Defibrillators (ICD) Market, United States, Volume (Units), 2018-2033
Table 33: Pacemakers Market, United States, Volume (Units), 2018-2033
Table 34: Cardiac Rhythm Management Devices Market, United States, Average Price ($), 2018-2033
Table 35: Cardiac Rhythm Management Devices Market, United States, Company Share by Revenue ($m), 2024
Table 36: Cardiac Rhythm Management Devices Market Pipeline Products
Table 37: Total Number of Primary Research Participants, Cardiovascular devices Market, by Country

List of Figure

List of Figures

Figure 1: Cardiac Rhythm Management Devices Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2018-2033
Figure 2: Cardiac Rhythm Management Devices Market, North America, Revenue ($m), USD Constant, 2018-2033
Figure 3: Cardiac Rhythm Management Devices Market, North America, Volume (Units), 2018-2033
Figure 4: Cardiac Rhythm Management Devices Market, North America, Volume (Units), 2018-2033
Figure 5: Cardiac Rhythm Management Devices Market, North America, Company Share (%), 2024
Figure 6: Cardiac Rhythm Management Devices Market, Canada, Revenue ($m), USD Constant, 2018-2033
Figure 7: Cardiac Resynchronisation Therapy (CRT) Market, Canada, Revenue ($m), USD Constant, 2018-2033
Figure 8: Implantable Cardioverter Defibrillators (ICD) Market, Canada, Revenue ($m), USD Constant, 2018-2033
Figure 9: Pacemakers Market, Canada, Revenue ($m), USD Constant, 2018-2033
Figure 10: Cardiac Rhythm Management Devices Market, Canada, Volume (Units), 2018-2033
Figure 11: Cardiac Resynchronisation Therapy (CRT) Market, Canada, Volume (Units), 2018-2033
Figure 12: Implantable Cardioverter Defibrillators (ICD) Market, Canada, Volume (Units), 2018-2033
Figure 13: Pacemakers Market, Canada, Volume (Units), 2018-2033
Figure 14: Cardiac Rhythm Management Devices Market, Canada, Company Share (%), 2024
Figure 15: Cardiac Rhythm Management Devices Market, Mexico, Revenue ($m), USD Constant, 2018-2033
Figure 16: Cardiac Resynchronisation Therapy (CRT) Market, Mexico, Revenue ($m), USD Constant, 2018-2033
Figure 17: Implantable Cardioverter Defibrillators (ICD) Market, Mexico, Revenue ($m), USD Constant, 2018-2033
Figure 18: Pacemakers Market, Mexico, Revenue ($m), USD Constant, 2018-2033
Figure 19: Cardiac Rhythm Management Devices Market, Mexico, Volume (Units), 2018-2033
Figure 20: Cardiac Resynchronisation Therapy (CRT) Market, Mexico, Volume (Units), 2018-2033
Figure 21: Implantable Cardioverter Defibrillators (ICD) Market, Mexico, Volume (Units), 2018-2033
Figure 22: Pacemakers Market, Mexico, Volume (Units), 2018-2033
Figure 23: Cardiac Rhythm Management Devices Market, Mexico, Company Share (%), 2024
Figure 24: Cardiac Rhythm Management Devices Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 25: Cardiac Resynchronisation Therapy (CRT) Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 26: Implantable Cardioverter Defibrillators (ICD) Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 27: Pacemakers Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 28: Cardiac Rhythm Management Devices Market, United States, Volume (Units), 2018-2033
Figure 29: Cardiac Resynchronisation Therapy (CRT) Market, United States, Volume (Units), 2018-2033
Figure 30: Implantable Cardioverter Defibrillators (ICD) Market, United States, Volume (Units), 2018-2033
Figure 31: Pacemakers Market, United States, Volume (Units), 2018-2033
Figure 32: Cardiac Rhythm Management Devices Market, United States, Company Share (%), 2024